ADQ establishes new healthcare giant: Abu Dhabi sovereign wealth fund ADQ has launched Arcera, a global life sciences holding company headquartered in Abu Dhabi, by combining three of the sovereign wealth fund’s healthcare assets, it said in a press release. The new entity will be headed by Isabel Afonso (LinkedIn), the former head of in-market brands and business innovation at Novartis.
The assets in question: Switzerland-based Acino International, a global pharma firm with a long history and operations across continents; Birgi Mefar Group, a Turkish sterile production and pharma distribution company; and Egypt’s Amoun, a manufacturer of human and animal health products.
About the new company: The new entity operates with a workforce of over 6.5k employees, conducting sales and distribution across over 90 countries. It offers 2k branded medicines across various therapeutic areas and boasts manufacturing and packaging facilities in the UAE, Switzerland, Ukraine, Estonia, South Africa, Turkey, and Egypt.
Next step: more acquisitions. The company wants to double its revenues over the next five years through strategic acquisitions and “global partnerships,” according to the statement.
…and an IPO? The company was reportedly eyeing consolidation of its assets ahead of a potential IPO for the company, Bloomberg reported in October 2023. The listing could take place over the next 12 or 18 months, the business information service said at the time.
Following the PureHealth blueprint: The sovereign wealth fund also consolidated its healthcare assets into Pure Health last year before listing the company and raising USD 1 bn in a blockbuster IPO.